| 产品详情 |
| Edit |   |
|---|
| Product Name | CCT196969 |
|---|
| Description | MW: 513.53. CCT196969, a pan-RAF/SFK inhibitor is active against treatment-naive BRAF and NRAS mutant melanoma tumors. It is also active in tumors from patients who developed resistance to BRAF-selective inhibitors and a BRAF plus MEK inhibitor combination. IC50 0.1µM and 0.03µM for BRAF kinase and SRC kinase respectively. |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | 1-(3-(tert-butyl)-1-phenyl-1H-pyrazol-5-yl)-3-(2-fluoro-4-((3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-8-yl)oxy)phenyl)urea; CCT-196969; CCT 196969 |
|---|
| Gene, Accession, CAS # | CAS: 1163719-56-9 |
|---|
| Catalog # | abx076818 |
|---|
| Price | |
|---|
| Order / More Info | CCT196969 from ABBEXA |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|